Lexaria Bioscience Corp. (LEXXW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 15.84M |
| Enterprise Value | 14.15M |
| P/E Ratio | -1.2 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 32.38 |
| Price/Book Ratio | 2.16 |
| Enterprise/Revenue | 18.7 |
| Enterprise/EBITDA | -0.73 |
| Fiscal Year | August 31, 2025 |
| Most Recent Quarter | February 28, 2026 |
| Profit Margin | -25.9 |
| Operating Margin | -25.72 |
| Return On Assets | -1.47 |
| Return On Equity | -1.9 |
| Revenue | 705,923 |
| Revenue/Share | 0.02 |
| Gross Profit | 703,203 |
| EBITDA | -11.82M |
| Net Income | -11.9M |
| Diluted EPS | -0.66 |
| Total Cash | 5.27M |
| Total Cash/Share | 0.22 |
| Total Debt | 94,386 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 26.88 |
| Book Value Per Share | 0.25 |
| 52-Week Change | -99.5 |
| 52-Week High | 0.03 |
| 52-Week Low | 0 |
| Moving Average 50 Days | 0.03 |
| Moving Average 200 Days | 0.16 |
| Average Volume | 12,494 |
| Shares Outstanding | 24.74M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |